6 November 2020This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…
5 November 2020Monitor infant for gastro-intestinal disturbances and oral candida infection, especially if used for prolonged periods or in high doses, although these effects are unlikely to…
Medicine Compliance Aid Stability
genericAurobindo Pharma - Milpharm Ltd
Aurobindo Pharma - Milpharm Ltd
Capsules 250mg, 500mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Powder is hygroscopic. Protect from light, moisture and store in airtight containers. Maximum 7 days in MCA.
18 March 2015
Lactation Safety Information
Very limited published evidence shows negligible amounts in breast milk
Monitor infant for gastro-intestinal disturbances and oral candida infection, especially if used for prolonged periods or in high doses, although these effects are unlikely to occur. There is also a theoretical risk of hypersensitivity
7 October 2021